Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist device
27 May 2018 (09:15 - 09:25)
Organised by:
Slides
About the speaker
Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
11 More presentations in this session
Professor D. Kotecha (Birmingham, GB)
Access the full session
The Event
Heart Failure 2018
27 May 2018
09:15 CET
You may be interested in
Congress Session
17 May 2025
Congress Session
19 May 2025
